Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonah J Scott-McKean

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
CNS Drugs|July 4, 2013
Prospects for improving brain function in individuals with Down syndromeAlberto C S Costa, Jonah J Scott-McKean
Learning & Memory (Cold Spring Harbor, N.Y.)|November 22, 2011
Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantineJonah J Scott-McKean, Alberto C S Costa
Neuroreport|May 19, 2006
Hypothermic responses to 8-OH-DPAT in the Ts65Dn mouse model of Down syndromeMelissa R Stasko, Jonah J Scott-McKean, Alberto C S Costa
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 19, 2007
Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning testAlberto C S Costa, Jonah J Scott-McKean, Melissa R Stasko
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2005
G-protein-gated potassium (GIRK) channels containing the GIRK2 subunit are control hubs for pharmacologically induced hypothermic responsesAlberto C S Costa, Melissa R Stasko, Markus Stoffel, et al.
The Open Neuropsychopharmacology Journal|March 31, 2010
5-HT(1A) Receptor Null Mutant Mice Responding Under a Differential-Reinforcement-of-Low-Rate 72-Second Schedule of ReinforcementJonah J Scott-McKean, Galen R Wenger, Laurence H Tecott, et al.
Investigative Ophthalmology & Visual Science|May 17, 2020
Quantitative Analysis of Retinal Structure and Function in Two Chromosomally Altered Mouse Models of Down SyndromeDaniella B Victorino, Jonah J Scott-McKean, Mark W Johnson, et al.
Stem Cells Translational Medicine|April 4, 2017
Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down SyndromeYoung M Lee, Bruna L Zampieri, Jonah J Scott-McKean, et al.
Neural Plasticity|June 1, 2018
Pharmacological Modulation of Three Modalities of CA1 Hippocampal Long-Term Potentiation in the Ts65Dn Mouse Model of Down SyndromeJonah J Scott-McKean, Adriano L Roque, Krystyna Surewicz, et al.
Gels (Basel, Switzerland)|April 3, 2021
Microcapillary Reactors via Coaxial Electrospinning: Fabrication of Small Poly(Acrylic Acid) Gel Beads and Thin Threads of Biological Cell DimensionsSusan K Kozawa, Audrey Lord, Jonah J Scott-McKean, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
CNS Drugs|July 4, 2013
Prospects for improving brain function in individuals with Down syndromeAlberto C S Costa, Jonah J Scott-McKean
Learning & Memory (Cold Spring Harbor, N.Y.)|November 22, 2011
Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantineJonah J Scott-McKean, Alberto C S Costa
Neuroreport|May 19, 2006
Hypothermic responses to 8-OH-DPAT in the Ts65Dn mouse model of Down syndromeMelissa R Stasko, Jonah J Scott-McKean, Alberto C S Costa
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 19, 2007
Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning testAlberto C S Costa, Jonah J Scott-McKean, Melissa R Stasko
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2005
G-protein-gated potassium (GIRK) channels containing the GIRK2 subunit are control hubs for pharmacologically induced hypothermic responsesAlberto C S Costa, Melissa R Stasko, Markus Stoffel, et al.
The Open Neuropsychopharmacology Journal|March 31, 2010
5-HT(1A) Receptor Null Mutant Mice Responding Under a Differential-Reinforcement-of-Low-Rate 72-Second Schedule of ReinforcementJonah J Scott-McKean, Galen R Wenger, Laurence H Tecott, et al.
Investigative Ophthalmology & Visual Science|May 17, 2020
Quantitative Analysis of Retinal Structure and Function in Two Chromosomally Altered Mouse Models of Down SyndromeDaniella B Victorino, Jonah J Scott-McKean, Mark W Johnson, et al.
Stem Cells Translational Medicine|April 4, 2017
Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down SyndromeYoung M Lee, Bruna L Zampieri, Jonah J Scott-McKean, et al.
Neural Plasticity|June 1, 2018
Pharmacological Modulation of Three Modalities of CA1 Hippocampal Long-Term Potentiation in the Ts65Dn Mouse Model of Down SyndromeJonah J Scott-McKean, Adriano L Roque, Krystyna Surewicz, et al.
Gels (Basel, Switzerland)|April 3, 2021
Microcapillary Reactors via Coaxial Electrospinning: Fabrication of Small Poly(Acrylic Acid) Gel Beads and Thin Threads of Biological Cell DimensionsSusan K Kozawa, Audrey Lord, Jonah J Scott-McKean, et al.
Pageof 2